First report of  in camels () in Ethiopia: bioassay and seroepidemiological investigation by unknown
Gebremedhin et al. BMC Veterinary Research 2014, 10:222
http://www.biomedcentral.com/1746-6148/10/222RESEARCH ARTICLE Open AccessFirst report of Toxoplasma gondii in camels
(Camelus dromedarius) in Ethiopia: bioassay
and seroepidemiological investigation
Endrias Zewdu Gebremedhin1*, Hasen Awel Yunus2, Gebregergs Tesfamaryam3, Tesfaye Sisay Tessema4,
Fufa Dawo5, Getachew Terefe5, Vincenzo Di Marco6 and Maria Vitale6Abstract
Background: Toxoplasmosis is a major public health concern in many countries of the world. A cross-sectional and
follow up experimental study designs were used for seroepidemiological and bioassay studies, respectively from
November 2012 to April 2013. The objectives were to estimate the seroprevalence of T. gondii infection, to assess
risk factors and to isolate the parasite from camels in the Fentale district, Ethiopia. A direct agglutination test (DAT)
and indirect enzyme linked immunosorbent assay (ELISA) kits were used to test camel sera. Hearts and tongues
(each 25 g) from 31 seropositive camels were bioassayed in mice. Associations between seroprevalence and
potential risk factors (collected using a questionnaire survey) were analyzed using logistic regression.
Results: An overall T. gondii prevalence of 49.62% (220/455) by DAT and 40.49% (179/451) by indirect ELISA test
were detected. Herd level seroprevalence of 96.77% (30/31) (95% CI: 83.30– 99.92) by DAT was recorded and it was
significantly higher in areas where wild felids are present (P = 0.038). Multivariable logistic regression showed that
the likelihood of acquiring T. gondii infection was significantly higher in camels in the Ilala pastoral association [PA]
(82.26%) (Adjusted Odds ratio [aOR] = 10.8; P < 0.001) than camels in the Galcha PA (31.43%), in camels of≥ 8 years
old (56.52%; aOR = 1.88; P = 0,033) than camels of≤ 4 years old (34.26%) and in areas where domestic cats are present
(aOR = 4.16; P = 0.006). All camel owners were uneducated, handle aborted fetus with bare hands, and drink raw camel
milk. DAT and ELISA tests had moderate agreement (Kappa = 0.41). Viable T. gondii were isolated from 16.13% (5/31) of
DAT positive camels. One DAT positive but ELISA negative camel sample gave a cyst positive result.
Conclusions: T. gondii infection of camels in the study district is widespread. Age, presence of domestic cats and study
PA are independent predictors of T. gondii seropositivity. Isolation of viable parasites from edible tissues of camels and
the very poor knowledge of pastoralists about toxoplasmosis suggest the need for prevention of toxoplasmosis
through bio-security measures, education and further investigation to unravel the impact of camel toxoplasmosis
deserves consideration.
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A population over 2.3 million camels is estimated in
Ethiopia [1], which is considered the third largest camel
populated country in the world. All camels in Ethiopia are
owned by pastoralists [2]. Camels play a central role in the
livelihood of pastoralists through provision of milk, meat,* Correspondence: endrias.zewdu@gmail.com
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article, unless otherwise stated.and draught power and they also determine their wealth
and social status [3]. Despite their social, ecological and
economic importance in Ethiopia, until recently they were
neglected by researchers and development planners and as
a result little is known about productivity and health prob-
lems in camels compared to other livestock [4,5].
Camels suffer from various parasitic diseases, including
toxoplasmosis, which have public health and economic
importance [6]. Toxoplasmosis is caused by an intracellu-
lar Apicomplexa protozoan, T. gondii, found worldwideentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Camels acquire T. gondii infection through ingestion or
inhalation of sporulated oocysts that are shed by cats or
wild felids in the environment [8]. The prevalence of
T. gondii infection in camels varies widely depending on
the localities of the world [9], ranging from 3.12% in Iran
[10] to 90.90% in Turkey [11].
T. gondii infects one-third of the world human popula-
tion. The infection can be life threatening during preg-
nancy and in immunocompromised individuals [12,13].
The disease is a major public health concern in many
countries of the world [14]. In USA, it is the third lead-
ing cause of death from foodborne diseases [12].
Humans become infected with T. gondii mostly by
ingesting raw or undercooked meat of infected animals or
by ingesting food or water contaminated with oocysts [13]
and the parasite can be transmitted to the fetus by the
passage of tachyzoites through the placenta [15]. The pres-
ence of T. gondii in milk [10] and edible tissues [16] of car-
rier camels indicate the possibility of transmission to
humans; particularly in pastoral communities in which
raw milk, and to some extent raw meat, can be frequently
consumed [17]. Recent reports from Ethiopia indicate high
seroprevalence of toxoplasmosis in women of child-
bearing age ranging from 70.29 to 87.4% [18-20].
Studies done in different parts of Ethiopia over the last
24 years indicated high seroprevalence of T. gondii infec-
tion in sheep [21-23], goats [21,22,24,25], cattle [21],
chicken [26] and cats [27]. However, there is no single
report of T. gondii infection in Ethiopian camels so far.
Although DAT and ELISA tests have been widely used for
detection of T. gondii infection in epidemiological studies,
there are no reports on the comparative evaluation of the
diagnostic capability of these diagnostic tests in naturally
infected camels. This report compares serodiagnostic
methods of T. gondii infection in camels using commercial
kits (DAT and ELISA), and isolation of the parasite from
edible camel tissues, to estimate the seroprevalence of
toxoplasmosis in camels. The role of the identified risk
factors on the parasite transmission is also discussed.
Methods
Study area and study animals
The study was conducted in the Fentale district (39.93°E to
39°56’0”E longitude and 8.975o N to 8.58’30” N latitude)
which is located in the East Shewa Zone of Oromia
Regional State, Ethiopia (Figure 1) at 190 Kms East of
Addis Ababa. It lies at an altitude range of 955-2007 meters
above sea level, and has an annual rainfall ranging from 560
millimeter (mm) to 630 mm and mean temperature ran-
ging from 29°C to 38°C. The vegetation comprises mix of
acacia trees, bushes and shrubs that are common to the
lowland areas of Ethiopia. With its arid and semi-arid cli-
mate, pastoral and agro-pastoral production systemspredominate in the area. The district is estimated to possess
48, 078 camels found in eighteen pastoral associations
(PAs). Pastoral and agro-pastoral production systems are
practiced in 11 and 7 PAs, respectively [28].
The study population consisted of camels of different age
groups in selected PAs of the district managed under the
two production systems. The camels of both sex groups
were classified by age into three categories (≤4 years, 4-8
years and > 8 years) [29]. Ages of camels were recorded
based on information from the owners and also estimated
according to their dentations [30].Study design, sample size determination and
sampling method
Cross-sectional and follow up experimental study de-
signs were used for seroepidemiological and bioassay
studies, respectively from November 2012 to April 2013.
Out of 18 PAs, a total of 6 PAs (pastoral = 3, agro-
pastoral = 3) were chosen conveniently based on accessi-
bility of the PAs. Camel herds in each of the selected
PAs were stratified by herd size into three: small (1-9),
medium (10-19) and large (≥20) camels [31]. Out of 58
camel herds found in the selected study PAs (n = 6), 31
herds were randomly selected using the lottery method.
Then, all camels in selected herds were used to collect
blood samples. Since there has been no previous study on
camel toxoplasmosis in Ethiopia, 50% expected prevalence
(P) and 95% confidence interval (Z = 1.96) with a 5% de-
sired absolute precision (d) was considered to arrive at the
required sample size (n = 384) for the seroepidemiological
study using the formula: n = P (1-P) Z2 /d2) [32]. Addition-
ally, purposive sampling of blood from 70 camels was con-
sidered for sample selection by serology in order to use
their heart and tongue for bioassay.Sample collection and transportation
Blood samples for serum separation were collected from
the jugular vein of apparently healthy camels using la-
beled plain vacutainer tubes following proper physical
restraining. For the bioassay, heart, tongue and blood
sample of purposively selected 70 camels, originating
from Fentale district but slaughtered at Akaki abattoir
near Addis Ababa, were collected. The collected samples
were kept in an icebox containing ice packs and immedi-
ately transported to the Ethio-Belgium post-graduate re-
search laboratory, College of Veterinary Medicine and
Agriculture, Debre Zeit, Ethiopia for serological testing
and isolation of T. gondii. Sera were separated by centri-
fugation at 3200 rpm for 10 minutes, decanted into
cryovials and stored at -20°C until used for serological
assay. Heart and tongue samples were kept at + 4°C for
1-3 days until serological results were known.
Figure 1 Map of the Fentale district showing sampled pastoral associations (PAs) (adapted from https://www.google.com.et/
search?q=Ethiopia+map&btnG=&tbm=isch&gws_rd=ssl).
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A close-ended questionnaire was designed and self-
administered to collect data about the potential risk fac-
tors for camels to acquire T. gondii infection. Awareness
of camel owners about toxoplasmosis including the
habits of consumption of raw camel meat and milk was
also documented. The questions in the questionnaire in-
cluded sex (male, female), age (≤4 years, 4-8 years and >
8 years), production system (pastoral/agropastoral), pres-
ence of cats (yes/no), presence of wild felids (yes/no),
source of drinking water (tap, stagnant: [lake, pond and
well], river, mixed [river and stagnant]) and herd size
(small:1-9, medium:10-19, large: ≥ 20 camels) [31]. Infor-
mation about history of abortion (yes/no), way of hand-
ling aborted fetus (wearing gloves, without wearing glove,
washing hand after handling, without washing hand after
handling) and method of disposal of aborted fetus (giving
to cat, throwing along the way, burying) were recorded.
Moreover, camel owners consumption habits of camel
meat (cooking, without cooking, both) and raw milk con-
sumption (yes/no), educational level (uneducated, primary
school, secondary school, tertiary/university) and aware-
ness about: toxoplasmosis (yes/no), role of cat to transmit
diseases to owner (yes/no), role of cat to transmit diseases
to camel (yes/no) and camel migration (yes/no) and routes
of migration were also gathered.
Laboratory investigation
Direct agglutination test (DAT)
All sera samples collected were examined for the presence
of antibodies (IgG) against T. gondii by the direct agglutin-
ation test (Toxo screen DA, biomerieux®, France) follow-
ing the protocol of the manufacturer. The kit was claimed
by the manufacturer to have sensitivity and specificity of
96.22% and 98.80%, respectively. Sera were assayed at a
screening dilution of 1:40 and 1:4000. A titer of 1:40 or1:4000 or both was considered indicative of T. gondii ex-
posure. Sedimentation of antigen at the bottom of the well
and clear agglutination above half of the well at either di-
lution were recorded as negative and positive results re-
spectively. DAT positive samples were titrated to know
the endpoint titer. Positive and negative controls were in-
cluded in each test.
Indirect enzyme linked immunosorbent assay (ELISA)
A total of 451 (381 from field and 70 from abattoir) sera
were tested for T. gondii IgG antibodies by the indirect
ELISA kit (ID VET Innovative Diagnostic, ID Screen®,
Montpellier, France) following the manufacturer’s in-
structions. The wells of the kit are coated with T. gondii
P30 (SAG1) surface antigen. The kit uses non-species spe-
cific protein conjugate that is used in several animal spe-
cies. For interpretation of the result S/P% was calculated
as: S/P% = (optical density [OD] 450 value of the sample –
OD 450 value of the negative control)/(mean OD 450
value of the positive control – OD 450 value of the nega-
tive control) × 100. Any sample with S/P% ≤ 40%, 40% -
50% and ≥ 50% were considered as negative, doubtful and
positive, respectively. With this cut-off the manufacturer
claims the test to have more than 99% specificity and sen-
sitivity. The test was considered valid if the mean OD
value of the positive control (ODPC) is greater than 0.350
(ODPC > 0.350) and the ratio of the mean OD value of the
positive and negative controls (ODPC and ODNC) is
greater than 3.5 (ODPC/ODNC> 3.5). The doubtful sera
were retested.
Bioassay
Heart and tongue tissue samples (pooled weight 50 g)
from DAT positive camels (n = 31) slaughtered at Akaki
abattoir, were processed for isolation of T. gondii as de-
scribed previously [13]. Briefly, each sample was cut into
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followed by soaking in 125 ml of saline solution for an-
other 30 seconds (0.14 M sodium chloride). After
homogenization 250 ml of pepsin solution (Merck KG.
A, Darmstadt, Germany) was added (pH = 1.1–1.2) and
incubated at 37°C for 1 h. The homogenate was filtered
through two layers of gauze and centrifuged at
3200 rpm for 10 minutes. The supernatant was dis-
carded and to the sediment 15 to 20 ml of 1.2% sodium
bicarbonate (pH = 8.3) was added and centrifuged at
3200 rpm for 10 min. The supernatant was discarded
and the sediment was re-suspended in 5 to 10 ml of
antibiotic saline solution (1000 U/ml penicillin and
100 μg of streptomycin/ml of saline solution). The sus-
pension was inoculated intraperitoneally (1 ml per
mouse) into five apparently healthy T. gondii seronega-
tive female Swiss-Albino mice (National Veterinary
Institute, Debre Zeit) per sample (weighting 25–35 g)
as described by Dubey [13]. Bioassays were performed
within 1-3 days of the slaughter of the camels. Separate
knives, cutting boards, gloves, plastic cups/falcon
tubes, and plastic bags for blending and pepsin diges-
tion were used for each sample to avoid contamination
among samples. Tissue homogenate kept in 6 falcon
tubes (50 ml) were centrifuged in 2 steps; the first and sec-
ond batch in 4 and 2 floating buckets of the centrifuge.
Approximately 110-140 minutes elapsed from the time
the tissue was homogenized in saline to the time the ma-
terial was pulled into syringes for mouse inoculation. The
inoculated mice were observed daily for illness for 60 days
and information on number of survivors, dead, day of
death, symptoms, and weight (initial and final) were re-
corded. The mice were fed with pelleted feed and munici-
pal chlorinated water ad-libitum. T. gondii isolate was
considered as virulent if 100% mortality of mouse was ob-
served within four weeks of infection [33].
Surviving mice were bled on day 60 after anesthetizing
with di-ethyl ether (Biolab laboratories ltd, Israel). Brains
of all mice were removed by sagittal dissection and then
examined for tissue cysts. The inoculated mice were con-
sidered infected with T. gondii when tissue cysts were
found in brain tissues and/or the sera of mice react posi-
tively for the commercial DAT. The brain was homoge-
nized in 1 ml phosphate buffer saline (PBS) by using a
mortar and pestle. The numbers of cysts in five aliquots of
each 10 μl were counted under microscope with a 10 ×
and 40 × objective lens and summed. The total number of
cysts in the brain of each mouse was determined by multi-
plying the number of cysts in the 50 μl sample examined
with the dilution factor [34].
Data management and analyses
The data generated from field and laboratory investiga-
tions were entered and coded using Microsoft Excel®2007 and analyzed using STATA version 11.0 for Win-
dows (Stata Corp. College Station, TX, USA). Descriptive
statistic was used to summarize the data. The informa-
tion from the questionnaire survey was used to define
explanatory variables to be tested in a logistic regression
model, for any assessment of association between the
serological status of the camels (dependent variable) and
the risk factors (independent variables). Initially, all risk
factors were individually screened by cross-tabulation
for association with the likelihood of T. gondii infection
using Chi-squared analysis. Non-collinear variables, with
P-value < 0.25 in the univariable analysis, were entered
into the multivariable logistic regression model. During
the analyses the clustering nature of the outcome within
a herd was considered by including herd as a clustering
variable. This enabled us to use a clustered sandwich es-
timator i.e., robust standard error rather than the stand-
ard error of the parameters estimated using maximum
likelihood method. The results of the logistic regression for
each variable were expressed as P-value and odds ratio
(OR) with 95% confidence intervals to measure the strength
of associations. The seroprevalence results of DAT and
ELISA tests were compared using the Chi-squared test and
their concordance was determined by calculating the Kappa
index. Using DAT as a reference test, the diagnostic sensi-
tivity (Se), specificity (Sp), positive predictive value (PPV)
and negative predictive value (NPV) of ELISA were calcu-
lated and interpreted following the recommendations of
Dohoo et al. [35]. A student t-test was employed to assess
the mean weight difference between seropositive and sero-
negative mice. Differences were considered significant when
P ≤ 0.05.
Ethical considerations
This research project was approved by the animal ethical
committee of the College of Veterinary Medicine and
Agriculture, Addis Ababa University. All efforts were
made to minimize animal suffering during the course of
the study. Informed written consents were obtained
from all camel owners who participated in the study.
Results
Animal level seroprevalence
An overall T. gondii prevalence of 49.62% (220/455) by
DAT and 40.49% (179/451) by indirect ELISA test were
detected. Out of the 218 DAT positive sera, 16 (7.34%)
were negative at 1:40 dilution but positive at 1:4000 dilu-
tion. The serum samples collected from the abattoir were
excluded from risk factor assessment because of missing
information for most variables. A statistically significant
difference in seroprevalence was observed between studied
PAs with the highest and lowest seroprevalence recorded
from Ilala (82.26%) and Galcha (31.43%) PAs, respectively
(P = 0.0001). The seroprevalence was also significantly
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0.011) and history of abortion (P = 0.003). However, there
was no statistically significant difference in seroprevalence
between males and females (P = 0.757) and pastoral and
agro-pastoral production systems (P = 0.683; Table 1).
Using ELISA, the PA (P = 0.003) and history of abortion
(P = 0.038) were significantly associated with seropositivity
(see Additional file 1: Table S1). Of the seropositive sam-
ples 73.8% (138/187) had DAT end titer of ≥ 6000. The
DAT end titer of the seropositive camels (n = 187) is
shown in Figure 2.
Herd level seroprevalence
Out of 31 camel herds examined, 30 (96.77%) (95% CI:
83.30– 99.92) and 29 (93.55%) (95% CI: 78.58– 99.21)
herds were seropositive by the DAT and ELISA test, re-
spectively (i.e., contain at least one seropositive camel).
Using DAT, herd level seroprevalence of T. gondii infec-
tion was not significantly associated with PAs (P = 0.372),
production system (P = 0.170), herd size (P = 0.576), his-
tory of abortion (P = 0.549) and presence of domestic catsTable 1 T. gondii seroprevalence in camels of the Fentale distri
Variable Categories No. tested No. positiv







Sex Female 209 100
Male 176 87
Age ≤4 yrs 108 37
4-8 yrs 185 98
>8 yrs 92 52
Ps Pastoral 308 148
Agro-pastoral 77 39
Hs Small 85 39
Medium 173 98
Large 127 50
Abortion No 198 90
Yes 11 10
Stillbirth No 207 98
Yes 2 2
NNM No 1 0
Yes 208 100
PA = pastoral association, Hs = herd size, Ps = production system, NNM = neonatal m
No. = number.(P = 0.549). However, there was significant association be-
tween herd seroprevalence and presence of wild felids
(P = 0.038; Table 2). Using ELISA, herd level seropreva-
lence was not associated with the studied variables except
neonatal mortality (see Additional file 1: Table S2).Risk factors for T. gondii seropositivity
Univariable logistic regression analysis
Epidemiological risk factors for acquiring T. gondii be-
tween DAT seroreactive and nonreactive camels were
compared using univariable logistic regression analysis.
During the statistical analysis the first level/category
(with lowest seroprevalence) of each independent vari-
able was used as the reference category. The results
showed that sex, herd size and production system had
no significant association with T. gondii seropositivity of
the camels (P > 0.05) while study area, age, history of
abortion, presence of domestic cats and presence of wild
felids were found to be significantly associated with
T. gondii infection (P < 0.05) (Table 3).ct, stratified by explanatory variables as detected by DAT
































Figure 2 DAT end titer of seropositive camels (n = 183).
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Stillbirth and neonatal mortality were not included in the
multivariable model due to collinearity with abortion. Five
variables (study area [PAs], age, abortion, exposure to do-
mestic and wild cats) that presented P-value < 0.25 in the
univariable analysis, were subjected to the multivariableTable 2 Herd level seroprevalence of T. gondii infection in cam
Variable Categories No. tested No. positiv






Ps Pastoral 20 20
Agro-pastoral 11 10
Hs Small 15 14
Medium 11 11
Large 5 5
Abortion Yes 8 8
No 23 21
Stillbirth Yes 3 3
No 28 27
NNM Yes 2 2
No 29 28
Cat Yes 8 8
No 23 22
Wf Yes 25 25
No 6 5
River Yes 29 29
PA = pastoral association, Hs = herd size, Ps = production system, Wf = presence of wregression model. The analysis showed a significant associ-
ation between T. gondii seropositivity and study area (PAs)
(P = 0.0001), age (P = 0.033) and the presence of domestic
cats (P = 0.006; Table 3). The results of the logistic regres-
sion analysis based on the results of the ELISA were pre-
sented as Additional file 1: Table S3).els of the Fentale district as detected by DAT























ild felids, NNM = neonatal mortality, No. = number.
Table 3 Animal level Logistic regression analysis of predictors of T. gondii infection in Camels as detected by DAT
Variable Category No. of positive/
tested (%)
Univariable Multivariable
OR (95% CI) P OR (95% CI) P
PA Galcha 11/35 (31.43) 1 1 -
Tuttuti 86/211 (40.75) 1.5 (0.58-3.88) 0.402 1.55 (0.60-3.99) 0.367
Saraweba 17/38 (44.74) 1.77 (0.45-6.97) 0.417 1.5 (0.63-3.58) 0.357
Garafafate 5/10 (50) 2.18 (0.87-5.45) 0.095 0.6 3 (0.17-2.33) 0.487
Turo 17/29 (58.62) 3.1 (.77-12.34) 0.110 1.06 (.23-4.94) 0.940
Ilala 51/62 (82.26) 10.11 (4.3-24.21) <0.001 10.8 (4.83-24.17) <0.001
Sex Female 100/209 (47.85) 1
Male 87/176 (49.43) 1.06 (0.70-1.62) 0.767
Age ≤4 yrs 37/108 (34.26) 1 1 -
4-8 yrs 98/185 (52.97) 2.16 (1.28-3.64) 0.004 1.73 (0.99-3.02) 0.053
>8 yrs 52/92( 56.52) 2.49 (1.34-4.65) 0.004 1.88 (1.05-3.37) 0.033
Ps1 Pastoral 148/308 (48.05) 1
Agro-pastoral 39/77 (50.65) 1.12 (0.46-2.64) 0.814
Cat No 173/305 (43.28) 1 1 -
Yes 55/80 (68.75) 2.88 (1.28-6.47) 0.010 4.16 (1.49-11.61) 0.006
Wf2 No 18/80 (22.5) 1 1 -
Yes 169/305 (55.41) 4.28 (2.40-7.63) <0.001 2.04 (0.86-4.83) 0.104
Abortion No 90/198 (45.45) 1 1 -
Yes 10/11 (90.91) 12.0 (1.25-114.96) 0.031 9.23 (0.8-107.05) 0.075
Hs3 Small 39/85 (45.88) 1
Medium 98/173 (56.65) 1.54 (0.59-4.01) 0.376
Large 50/127 (39.37) 0.76 (0.26-2.29) 0.633
1Production system, 2Wild felids, 3Herd size.
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about toxoplasmosis
All (100%) camel owners who responded to the ques-
tionnaire survey were uneducated pastoralists, had no
awareness about T. gondii, toxoplasmosis and its trans-
mission to humans through raw meat and raw milk con-
sumption. Camel meat consumption habit showed that
67.7% consume cooked meat and the rest (32.3%) con-
sume either cooked or uncooked meat. All respondents
(100%) consume raw camel milk, handle aborted fetus
with bare hands (no protection) and don’t wash their
hands after handling aborted fetus. Furthermore, none of
the camel owners bury or burn aborted materials; rather
they simply dispose of by throwing it in the field.
Comparison of seroprevalence results of DAT and
ELISA tests
Overall, the 451 serum samples were tested by both
DAT and ELISA kits for comparison. A total agreement
between the two tests was obtained on 132 positive sam-
ples (29.27%) and 186 (41.24%) negative samples. But 86
sera were positive only by DAT test and 47 sera were
positive only by ELISA test. Comparison of the two testresults indicated that seropositivity differed significantly
between the two kits (χ2 = 76.714, P < 0.001). However,
Kappa analysis demonstrated that the two tests had a
moderate agreement in detecting T. gondii infection in
camels (70.51% agreement, Kappa = 0.41; P < 0.0001). By
considering DAT as a reference test, the sensitivity, spe-
cificity, and positive and negative predictive values of
ELISA was calculated as 60.55%, 79.83%, and 73.74%
and 68.38%, respectively.
Bioassay
Of the 70 camel sera from the abattoir, 33 (47.1%) (95% CI:
35.09-59.45) and 29 (41.43%) (95% CI: 29.77-53.83) were
IgG seropositive using DAT and ELISA, respectively. Viable
T. gondii cysts were isolated from 5 of 31 DAT seropositive
bioassayed camels (16.13%). Out of the 31 DAT positive
sera, 22 were positive for ELISA and one ELISA negative
camel sample gave a cyst positive result. For two seroposi-
tive camel samples, isolation of the parasite was not pos-
sible because of the death of all of the inoculated mice
within a day of inoculation. On day 60 post-inoculation,
out of 108 mice that survived, 22 (20.4%) were seropositive
for T. gondii infection (i.e., out of 31 camel samples, 10
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cysts were isolated in mice from 5 tissue samples from
the camels (on 5 seropositive and 1 seronegative mice)
(Table 4). It was not possible to detect cysts from 17 of
the seropositive mice. Eleven out of 108 survived mice
showed loss of weight (10.2%), of which 9 and 2 mice
were seropositive and seronegative, respectively, i.e.,
40.9% (9/22) of seropositive and 2.3% (2/86) of sero-
negative mice showed loss of weight. The mean weight
change between seropositive (infected, mean = 0.25 g ±
6.58) and seronegative (non-infected, mean = 5.55 g ±
3.41) mice was significantly different (P < 0.0001). The
mean cyst count per mouse brain was 46.5 (range: 28 –
88). One mouse that showed neurological signs (hind
quarter paralysis, torticollis) and tachypnoea on day 20
post-inoculation became cyst negative but seropositive.Table 4 Isolation of T. gondii from naturally infected seroposi
Camel no. Sex Age group DAT screening Mice with cyst/exa
H1 M ≥8 Yrs 1/40 0/5
H2 M ≥8 Yrs 1/40 & 1/4000 0/5
H4 M 4-8 Yrs 1/40 & 1/4000 1/5
H6 M ≥8 Yrs 1/40 0/3
H9 M ≥8 Yrs 1/40 & 1/4000 2/5
H11 M 4-8 Yrs 1/40 & 1/4000 0/4
H15 F ≥8 Yrs 1/40 & 1/4000 0/3
H19 M ≥8 Yrs 1/40 1/5
H20 M ≥8 Yrs 1/40 & 1/4000 1/5
H23 M ≤ 4 Yrs 1/4000 0/3
H25 M ≥8 Yrs 1/40 & 1/4000 1/3
H28 F ≤ 4 Yrs 1/40 & 1/4000 0/4
H30 F ≥8 Yrs 1/40 & 1/4000 0/1
H33,H43 F ≥8 Yrs 1/40 & 1/4000 0/5
H39 M ≥8 Yrs 1/4000 0/5
H44 F 4-8 Yrs 1/40 & 1/4000 0/5
H45 F 4-8 Yrs 1/40 & 1/4000 0/4
H55 F ≤ 4 Yrs 1/40 & 1/4000 0/3
H56,H60,H65 F 4-8 Yrs 1/40 & 1/4000 0/5
H63 F 4-8 Yrs 1/4000 0/5
H59 M 4-8 Yrs 1/4000 0/4
H61,H64 F 4-8 Yrs 1/4000 0/4
H62 F 4-8 Yrs 1/40 & 1/4000 0/4
H66 F ≤ 4 Yrs 1/4000 0/5
H67 F ≥8 Yrs 1/40 & 1/4000 0/4
H68 M 4-8 Yrs 1/40 & 1/4000 0/3
H69 F ≥8 Yrs 1/40 & 1/4000 0/1Discussion
Overall seroprevalence
We report for the first time evidence for T. gondii infection
and its seroprevalence, risk factors and bioassay results in
Ethiopian camels. An estimated overall seroprevalence of
49.623% by DAT and 40.49% by ELISA tests were detected.
Seventy-four percent of seropositive camels (from field
samples) had DAT end titer of ≥ 6000. This might indicate
actively circulating, recently acquired or recrudescence of
previously acquired T. gondii infection in camels of the
study area due to climatic stress, malnutrition and preva-
lent diseases like trypanosomosis [36] which reduce the ani-
mals’ resistance [37]. Moreover, the seropositive sera that
became negative at 1:40 but positive at 1:4000 dilutions
(7.34%, 16/218) indicate prozone phenomenon. Presence of
viable T. gondii cysts in 16.13% (5/31) of camels slaughteredtive camels of East Shewa Zones, Central Ethiopia
mined (n) Mice seropositive/examined (n) Days of mice death
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gondii infection and suggests the potential transmission of
toxoplasmosis to humans through consumption of raw or
undercooked camel meat or offal such as the liver which is
commonly consumed by pastoralists. Considering the lower
human population density (hence possibly lower domestic
cat density), the arid and semi-arid climate of the Fentale
district, which is hostile for the survival of oocysts in the
environment, and the browsing habit of camel feeding
(hence lower risk of acquiring T. gondii oocysts from the
ground), the high seroprevalence found in the present study
was not to our expectation. Recently, a relatively lower
seroprevalence of T. gondii in goats (15.37%) [25] and in
sheep (13.36%) [23] was reported from the same district.
However, the high seroprevalence in camels of the current
study in our opinion might be a function of cumulative ef-
fect of the age of camels [38] related to absence of regular
culling programs. Moreover, the migration of camels to
midland areas in search of feed, the poor veterinary service,
inadequate attention by government, local change in land-
ownership and increased farming [5] - which necessitate
cat keeping to control rodents, might have additionally con-
tributed to the high prevalence. The present seroprevalence
(48.34%) is in close agreement with the 51.3% and 46% -
54.2% seroprevalence reported from Sudan [39] and Egypt
[40,41], respectively. As compared to the present finding,
much higher seroprevalence has been reported from
Turkey (90.9%) and Sudan (67%) by Utuk et al. [11] and
Elamin et al. [8], respectively. Lower seroprevalence was
recorded earlier from Iran 3.12% [10], Saudi Arabia 6.5%
[42], 16% [43], 13.1% [44], Sudan (20%) [45], United Arab
Emirates (22.4%) [46] and Egypt (17.4 - 31.4%) [9,47,48].
The variation in seroprevalence between the present study
and aforementioned African and Arabian countries might
be due to the difference in density of cats and wild felids,
climatic conditions [13], farming and management prac-
tices [49], sample size [45], cut-off values and sensitivity
difference in the serological tests employed [13,42].
Risk factors
Assessment of the association of T. gondii seroprevalence
with potential risk factors was made with the aim of iden-
tifying factors relevant for prevention of the disease. Ac-
cordingly, using the results of DAT, a multivariable logistic
regression model revealed that study PA (P = 0.001), ex-
posure to domestic cats (P = 0.006) and age of the camels
(P = 0.033) were found to be independent predictors of T.
gondii seropositivity. On the other hand, only study PA
(P = 0.006) and exposure to domestic cats (P = 0.011) were
found to be independent predictors of T. gondii seroposi-
tivity using results of ELISA (see Additional file 1). This
suggests that DAT is a more preferred test for assessing
the risk factors in camels than ELISA. Camels from Ilala
PA (82.26%) are 10.8 times more likely to be seropositivethan camels of Galcha PA (31.43%) [P < 0.001]. The ob-
served difference in seroprevalence across PAs could be
due to differences in the age of camels sampled [50], the
sample size [44], the degree of environmental contamin-
ation [13] and the frequency of exposure to risk factors
[51]. The seroprevalence of T. gondii infection was higher
in camels older than 8 years (OR = 2.49, 95% CI: 1.34,
4.65) as compared to camels ≤ 4 years old. Thus, the prob-
ability of T. gondii infection in camels increases as the age
of the animal increases suggesting postnatal infection. The
high seroprevalence in older camels than young camels
might be due to the higher likelihood of exposure of older
camels to any one of the risk factors to acquire T. gondii
infection [52]. This finding is in harmony with the studies
conducted in Saudi Arabia [8,43] who reported a higher
seroprevalence in adult than young camels.
The univariable logistic regression showed that the odds
of being infected by T. gondii infection was higher in
aborted camels than non-aborted camels (OR = 12, 95% CI:
1.25, 114.95; P = 0.031) and in areas where the presence of
wild felids was reported (OR = 4.28, 95% CI: 2.40, 7.63; P <
0.001) than in their absence. However, these variables were
not independent predictors of seropositivity in the final lo-
gistic regression model (P > 0.05). The high seroprevalence
in aborted camels is consistent with biological features of T.
gondii in sheep, goats and pigs. T. gondii has been reported
as an important cause of abortion in Bacterian camels [53]
and in zoo camels in USA [54].
There was no statistically significant sex-linked difference
in seroprevalence between male (49.43%; 95% CI: 42.0,
56.86) and female (47.85%; 95% CI: 41.0, 54.65) camels.
This is consistent with studies in dromedaries of Sudan [8],
Saudi Arabia [43] and bactrian camels of China [55].
Bioassay
As far as the bioassay result is concerned, tissue cysts
were isolated from 16.13% (5∕31) of DAT positive
camels. Bradyzoite tissue cysts were detected by mi-
croscopy in 22.73% (5/22) of DAT positive mice. This
lower rate of detection of cyst by microscopy might be
due to the low number of cysts in camel tissue and the
low sensitivity of microscopy [13]. Cyst count has also
been reported to vary depending on the virulence of T.
gondii strain and number of passages in the mice [56].
Previously, viable tissue cysts have been isolated in cats
from naturally infected camels in Saudi Arabia [16]. It
has also been reported that the success of isolation of
T. gondii cysts as well as the number of tissue cysts
produced vary considerably with the intermediate
hosts, being higher in sheep, goats and pigs [49,57].
The number of isolated tissue cysts ranged from 25 to
88 per brain of mice, which is low compared to the
number of cysts/mouse brain isolated from sheep and
goats of the same district (Gebremedhin et al.,
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detect the DNA of tissue cysts in the brain of seroposi-
tive mice presently reported perhaps as false negative
due to the small volume of brain homogenate examined
(50 μl), lower sensitivity of microscopy and the possible
low burden of viable cysts in tissue of camels [13]. Even
though detection of brain cysts was not possible, mani-
festations of tachypnoea and neurological signs by a
mouse on day 20 post-inoculation might indicate the
more virulent nature of the strain [13]. The death of
mice in less than 3 days following i.p. inoculation was
attributed to septic peritonitis that resulted from bac-
terial contamination of isolates or unintended punctur-
ing of the intestine or other vital organs [34].Comparison of seroprevalence results of DAT and ELISA
Comparison of the diagnosis of T. gondii infection of
camels by DAT and ELISA showed moderate agreement
(Kappa = 0.41, P < 0.0001). We think that the discrepan-
cies between the results of DAT and ELISA might be as-
cribed to the difference in the sensitivity and specificity
of the tests in camel. DAT is more sensitive than ELISA
which is in accordance with findings of Dubey [58] and
Shaapan et al. [59] who reported DAT as the most sensi-
tive test among all serological tests. It has also been re-
ported that test performances may vary when applied
on different animal species [60]. For example, as op-
posed to our finding, Zhu et al. [61] from Beijing,
China, reported significantly high T. gondii seropreva-
lence by ELISA (34.7%) as compared to DAT (23.1%, cut-
off:1:25) in dogs (high degree of agreement, Kappa =
0.644), while no significant difference between the two
tests was reported in the case of cats. The P30 ELISA test
we used in the current study employs non-species specific
conjugate and was recommended by the manufacturer
to detect anti-T. gondii antibodies in ruminant, cat or
pig sera, plasma or meat juice. However, literature with
regards to validation of this kit for camels was not ac-
cessible; consequently comparison of our results with
others couldn’t be made possible. Nevertheless, isola-
tion of viable cysts from four of five camels positive by
ELISA (out of ten camel tissues positive by bioassay
using DAT, seven were also ELISA positive) coupled
with the relatively higher specificity (79.83%) and PPV
(73.74%) of ELISA in the present study, suggests the
usefulness of the P30 ELISA test in epidemiological
studies of camel toxoplasmosis particularly among
highly disease prevalent populations and in instances of
abortion storms [62]. Although in the present study
DAT is more sensitive than ELISA, the subjective nature
and longer waiting time before reading the results might
limit widespread and large scale usage of DAT for epi-
demiological studies [61].Camel owners’ food habit and awareness about
toxoplasmosis
From the questionnaire data it was evident that all of
the respondents were uneducated and have a very poor
knowledge of T. gondii and its mode of transmission be-
tween animals, to humans and the role of felids in the
epidemiology of the disease. The lack of knowledge
about the disease is one of the main risk factors expos-
ing individuals to the disease, as all of them drink raw
camel milk and 32.3% responded that they eat either
cooked or raw camel meat.
Human cases of toxoplasmosis have previously been
linked directly to the consumption of raw goat’s milk
[63] and camel milk [8]. Recently, T. gondii tachyzoites
have been detected from milk of naturally infected
camels in Iran using ELISA, PCR, cell culture and cat
bioassay [10] and from experimentally infected camels in
Sudan [64]. The high seropositivity and moderately high
rate of isolation of viable tissue cysts from edible organs in
the current study might be of great public health signifi-
cance. This is due to the deep rooted habit of consumption
of raw camel milk, offal (liver) and to a lesser extent, meat
by the pastoral communities of the study area. Moreover,
the absence of precautions in handling aborted materials
and poor knowledge of pastoralists about toxoplasmosis
and the role of cats in the transmission of the disease are
additional suggestive evidences for the spread of toxoplas-
mosis to humans and among camels in the study district.
In the absence of a vaccine for camels and the difficulty in
changing the pastoral extensive livestock management sys-
tem to intensive management to reduce the prevalence of
the disease, prevention of the disease through education
of pastoralists remains a better alternative and perhaps a
more economically feasible option to combat the disease.
The limitations of the current study include inter-
viewee recall bias, the relatively small number of camels
considered for bioassay and the inability to genotype the
isolates due to a shortage of resources. Further studies
to improve the sensitivity and specificity of ELISA for
diagnosis of toxoplasmosis in camels are required.
Conclusions
T. gondii infection of camels in the study district is wide-
spread. Age, presence of domestic cats and study PA are
independent predictors of T. gondii seropositivity. Isola-
tion of viable parasites from edible tissues of camels and
the very poor knowledge of pastoralists about toxoplasmo-
sis, suggest that people are at a higher risk of acquiring T.
gondii infection. Therefore, prevention of toxoplasmosis
through biosecurity measures, education of pastoralists
about the identified risks and further investigation to
unravel the economic and public health implications of
the high prevalence of T. gondii in the area deserves
consideration.
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